Table 1 Summary of clinical, echo, and right heart catheterization findings (N = 25).

From: Long term development of diastolic dysfunction and heart failure with preserved left ventricular ejection fraction in heart transplant recipients

Age (years)

60 ± 9

Number of males (%)

21 (84%)

Body mass index (kg/m2)

30 ± 4.3

Hypertension (%)

25 (100%)

Diabetes Mellitus (%)

10 (40%)

Hypertension treatment with diuretics

7 (28%)

Hypertension treatment with beta-blockers

4 (16%)

Hypertension treatment with calcium channel blockers

12 (48%)

Hypertension treatment with ACEI or ARB

8 (32%)

Patients on aspirin

24 (96%)

Patients on statins

22 (88%)

 ≥ 1 episodes of acute cellular rejection grade 2R or 3R

11 (44%)

 ≥ 1 episodes of acute cellular rejection grade 1R

18 (72%)

Cytomegalovirus status mismatch between donor and recipient hearts

8 (32%)

Patients on Prednisone (dose 5 mg daily)

14 (56%)

Patients on Tacrolimus

21 (84%)

Patients on Rapamycin

2 (8%)

Patients on Cyclosporine

3 (12%)

Patients on Mycophenolate

15 (60%)

Hemoglobin (gm/dl)

14 ± 1.8

Creatinine (mg/dl)

1.2 ± 0.3

Brain natriuretic peptide (pg/ml)

72 ± 36

Average mitral annulus early diastolic velocity (cm/s)

9 ± 2

Average E/e’ ratio

9.8 ± 2.8

Left atrium maximum volume index (mL/m2)

43 ± 11

Left atrium reservoir strain (%)

19.6 ± 6.1

Left ventricle global longitudinal strain or GLS (%)

 − 16.9 ± 2.6

Mean right atrial pressure (mmHg)

7 ± 3

Pulmonary artery systolic pressure (mmHg)

29 ± 6

Pulmonary artery diastolic pressure (mmHg)

14 ± 5

Mean Pulmonary Artery Pressure (mmHg)

19 ± 5

Mean pulmonary capillary wedge pressure (mmHg)

13 ± 5

  1. ACEI Angiotensin converting enzyme inhibitor, ARB Angiotensin receptor blocker.